Herbas VPB

Print
EN | LT
LT - 2, 4-Pirimidindiaminai, naudingi neoplastinių ligų, uždegiminių ir imuninės sitemos sutrikimų gydyme
EN - 2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 239/48 (2006.01)
C07D 405/12 (2006.01)
C07D 403/12 (2006.01)
C07D 401/12 (2006.01)
C07D 401/14 (2006.01)
A61K 31/506 (2006.01)
A61K 35/00 (2006.01)
A61P 37/00 (2006.01)
A61P 29/00 (2006.01)
European patent
(11) Number of the document 1660458
(13) Kind of document T
(96) European patent application number 04764093.3
Date of filing the European patent application 2004-08-13
(97) Date of publication of the European application 2006-05-31
(45) Date of publication and mention of the grant of the patent 2012-01-25
(46) Date of publication of the claims translation 2012-05-25
PCT application
(86) Number PCT/EP2004/009099
Date 2004-08-13
PCT application publication
(87) Number WO 2005/016894
Date 2005-02-24
Priority applications
(30) Number Date Country code
0319227 2003-08-15 GB
0322370 2003-09-24 GB
Inventors
(72)
GARCIA-ECHEVERRIA, Carlos, CH
KANAZAWA, Takanori, JP
KAWAHARA, Eiji, JP
MASUYA, Keiichi, JP
MATSUURA, Naoko, JP
MIYAKE, Takahiro, JP
OHMORI, Osamu, JP
UMEMURA, Ichiro, JP
STEENSMA, Ruo, US
CHOPIUK, Greg, US
JIANG, Jiqing, US
WAN, Yongqin, US
DING, Qiang, US
ZHANG, Qiong, US
GRAY, Nathanael, Schiander, US
KARANEWSKY, Donald, US
Grantee
(73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH
Attorney or representative
(74) Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) 2, 4-Pirimidindiaminai, naudingi neoplastinių ligų, uždegiminių ir imuninės sitemos sutrikimų gydyme
  2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS
Last renewal fee
Payment date Validity (years) Amount
2021-07-27 18 347.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2022-08-13